Cytori Therapeutics Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
CYTX Nasdaq 3841 http://www.cytori.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cytori Therapeutics Inc

Cytori Reports Sustained Benefit of Cell Therapy in Erectile Dysfunction Trial - Jul 8th, 2018 10:00 pm
Cytori Reports Improved Skin Healing in Pivotal Burn Preclinical Study - Jun 28th, 2018 7:00 am
Benzinga's Daily Biotech Pulse: Pain Therapeutics Drops 70%, Neon To Begin Trading - Jun 27th, 2018 6:14 am
Cytori Therapeutics Reminds Investors of Today’s Deadline to be a Shareholder of Record - Jun 22nd, 2018 10:00 am
Cytori Informs Stockholders of Key Dates and Terms Related to Announced Rights Offering - Jun 12th, 2018 6:30 am
Cytori Therapeutics Inc (NASDAQ:CYTX): Are Analysts Optimistic? - May 25th, 2018 1:37 pm
Benzinga's Daily Biotech Pulse: Eiger And Melinta Fall On Offerings, Apellis And Marinus Rise On Bullish Ratings - May 24th, 2018 6:37 am
Cytori Therapeutic’s common stock to begin trading on adjusted basis on May 24, following one-for-ten reverse split - May 23rd, 2018 2:55 pm
Edited Transcript of CYTX earnings conference call or presentation 10-May-18 9:30pm GMT - May 18th, 2018 6:19 pm
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Cytori Therapeutics, Inc. - May 18th, 2018 3:33 pm
Cytori: 1Q Earnings Snapshot - May 10th, 2018 5:43 pm
Cytori Reports Q1 2018 Business and Financial Results - May 10th, 2018 2:25 pm
Cytori to Webcast First Quarter Financial Results on May 10 - May 7th, 2018 2:15 pm
Cytori Provides Update on US Manufacturing and EU Approval Plans for ATI-0918, Liposomal Doxorubicin - Apr 30th, 2018 6:30 am
Blog Exposure - Biohaven Reported Positive Top-line Results For its Two Pivotal Phase-3 Trials of Rimegepant - Mar 28th, 2018 5:40 am
Edited Transcript of CYTX earnings conference call or presentation 8-Mar-18 10:30pm GMT - Mar 12th, 2018 11:16 am
Cytori reports 4Q loss - Mar 9th, 2018 3:00 am
Want To Invest In Cytori Therapeutics Inc (NASDAQ:CYTX)? Here’s How It Performed Lately - Mar 8th, 2018 11:39 am